Skip to main content
Equibles
CLPT logo

CLPT · ClearPoint Neuro, Inc.

Track CLPT — free

Use CLPT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CLPT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$15.34 -0.08 (-0.52%) At close · Aug 14
Market Cap
$467.93M
Shares
30.50M

ClearPoint Neuro, Inc. Earnings Call Transcripts

Every quarterly earnings call for ClearPoint Neuro, Inc. (CLPT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲52.4% $5.20M −$4.30M '22 Q2 22-08-09 ▲12.5% $5.15M −$3.79M '22 Q3 22-11-08 ▲8% $5.43M −$5.61M '23 Q1 23-05-11 ▲14.4% $5.95M −$7.05M '23 Q2 23-08-08 ▲12% $5.76M −$4.81M '23 Q3 23-11-09 ▲31.6% $6.81M −$4.62M '23 Q4 24-01-08 ▲40.6% $7.64M −$4.15M '24 Q1 24-05-07 ▲32.1% $7.86M −$4.41M '24 Q2 24-08-07 ▲41% $8.12M −$4.97M '24 Q3 24-11-07 ▲14.1% $7.77M −$5.39M '24 Q4 25-02-26 ▲11.1% $8.48M −$6.03M '25 Q1 25-05-13 ▲17.3% $9.21M −$5.84M '25 Q2 25-08-12 ▲9.1% $8.86M −$5.89M '25 Q3 25-11-06 ▲34% $10.41M −$7.79M '25 Q4 26-03-17 ▲42.9% $12.13M −$9.55M '26 Q1 26-05-13 LATEST ▲18.1% $10.88M −$11.34M '26 Q2 26-08-03
Earnings call
FY26 · Q2
2026-08-03
Second Quarter 2026 Financial Results Call
Confident tone FDA regulatory pathway acceleration Focused ultrasound partnership Commercial readiness for partner drug launches
Revenue
$10.88M
▲ 18.1% YoY
Diluted EPS
$-0.38
Gross margin
61.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
ClearPoint Neuro, Inc. Q1 FY2026 Earnings Call
Confident tone Biopharma partner ecosystem and cell/gene therapy pipeline Eeroflow acquisition integration Expense growth and cash burn
Revenue
$12.13M
▲ 42.9% YoY
Diluted EPS
$-0.32
Gross margin
64.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
ClearPoint Neuro, Inc. Q4 FY2025 Earnings Call
Confident tone Four product categories / Fast Forward phase Eris Holdings acquisition integration Cell and gene therapy / Essential Everywhere strategy
Revenue
$10.41M*
▲ 34% YoY
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
ClearPoint Neuro, Inc. Q3 FY2025 Earnings Call
Revenue
$8.86M
▲ 9.1% YoY
Diluted EPS
$-0.21
Gross margin
63.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
ClearPoint Neuro, Inc. Q2 FY2025 Earnings Call
Revenue
$9.21M
▲ 17.3% YoY
Diluted EPS
$-0.21
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
ClearPoint Neuro, Inc. Q1 FY2025 Earnings Call
Revenue
$8.48M
▲ 11.1% YoY
Diluted EPS
$-0.22
Gross margin
60.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
ClearPoint Neuro, Inc. Q4 FY2024 Earnings Call
Revenue
$7.77M*
▲ 14.1% YoY
Gross margin
61.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
ClearPoint Neuro, Inc. Q3 FY2024 Earnings Call
Revenue
$8.12M
▲ 41% YoY
Diluted EPS
$-0.18
Gross margin
59.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
ClearPoint Neuro, Inc. Q2 FY2024 Earnings Call
Revenue
$7.86M
▲ 32.1% YoY
Diluted EPS
$-0.16
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
ClearPoint Neuro, Inc. Q1 FY2024 Earnings Call
Revenue
$7.64M
▲ 40.6% YoY
Diluted EPS
$-0.16
Gross margin
59.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
ClearPoint Neuro, Inc. Q4 FY2023 Earnings Call
Confident tone Biologics and Drug Delivery Growth International Expansion and EU MDR Certification Four-Pillar Growth Strategy
Revenue
$6.81M*
▲ 31.6% YoY
Gross margin
58.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
ClearPoint Neuro, Inc. Q3 FY2023 Earnings Call
Revenue
$5.76M
▲ 12% YoY
Diluted EPS
$-0.20
Gross margin
56.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
ClearPoint Neuro, Inc. Q2 FY2023 Earnings Call
Revenue
$5.95M
▲ 14.4% YoY
Diluted EPS
$-0.29
Gross margin
52.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
ClearPoint Neuro, Inc. Q1 FY2023 Earnings Call
Revenue
$5.43M
▲ 8% YoY
Diluted EPS
$-0.23
Gross margin
58.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-11-08
ClearPoint Neuro, Inc. Q3 FY2022 Earnings Call
Revenue
$5.15M
▲ 12.5% YoY
Diluted EPS
$-0.15
Gross margin
71.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
ClearPoint Neuro, Inc. Q2 FY2022 Earnings Call
Revenue
$5.20M
▲ 52.4% YoY
Diluted EPS
$-0.18
Gross margin
62.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
ClearPoint Neuro, Inc. Q1 FY2022 Earnings Call
Revenue
$5.03M
▲ 24.8% YoY
Diluted EPS
$-0.17
Gross margin
64.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-14
ClearPoint Neuro, Inc. Q4 FY2021 Earnings Call
Revenue
$4.28M*
▲ 15.2% YoY
Gross margin
74.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
ClearPoint Neuro, Inc. Q3 FY2021 Earnings Call
Revenue
$4.57M
▲ 30% YoY
Diluted EPS
$-0.18
Gross margin
66.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
ClearPoint Neuro, Inc. Q2 FY2021 Earnings Call
Revenue
$3.41M
▲ 37.7% YoY
Diluted EPS
$-0.17
Gross margin
66.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
ClearPoint Neuro, Inc. Q1 FY2021 Earnings Call
Revenue
$4.03M
▲ 29.3% YoY
Diluted EPS
$-0.13
Gross margin
64.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
ClearPoint Neuro, Inc. Q4 FY2020 Earnings Call
Revenue
$3.72M*
▲ 15.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
ClearPoint Neuro, Inc. Q3 FY2020 Earnings Call
Revenue
$3.52M
▲ 20.2% YoY
Gross margin
74.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-12
ClearPoint Neuro, Inc. Q2 FY2020 Earnings Call
Revenue
$2.48M
▼ 4.9% YoY
Gross margin
67.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-16
ClearPoint Neuro, Inc. Q1 FY2020 Earnings Call
Revenue
$3.12M
▲ 26% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1285550 CUSIP 18507C103 13F (30d) 126 filings 123 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)